Drug Profile
Research programme: targeted apoptosis stimulants - Antisoma
Alternative Names: AS 1406; HMFG1-RNase; huHMFG1-RNase; TheraNaseLatest Information Update: 17 Sep 2007
Price :
$50
*
At a glance
- Originator Antisoma; National Cancer Institute (USA)
- Developer Antisoma
- Class Immunoconjugates; Monoclonal antibodies
- Mechanism of Action Apoptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer